Abstract

Aim: Traumatic brain injury (TBI) is a leading cause of mortality/morbidity and is associated with chronic neuroinflammation. Melanocortin receptor agonists including adrenocorticotropic hormone (ACTH) ameliorate inflammation and provide a novel therapeutic approach. We examined the effect of long-acting cosyntropin (CoSyn), a synthetic ACTH analog, on the early inflammatory response and functional outcome following experimental TBI.Methods: The controlled cortical impact model was used to induce TBI in mice. Mice were assigned to injury and treatment protocols resulting in four experimental groups including sham + saline, sham + CoSyn, TBI + saline, and TBI + CoSyn. Treatment was administered subcutaneously 3 h post-injury and daily injections were given for up to 7 days post-injury. The early inflammatory response was evaluated at 3 days post-injury through the evaluation of cytokine expression (IL1β and TNFα) and immune cell response. Quantification of immune cell response included cell counts of microglia/macrophages (Iba1+ cells) and neutrophils (MPO+ cells) in the cortex and hippocampus. Behavioral testing (n = 10–14 animals/group) included open field (OF) and novel object recognition (NOR) during the first week following injury and Morris water maze (MWM) at 10–15 days post-injury.Results: Immune cell quantification showed decreased accumulation of Iba1+ cells in the perilesional cortex and CA1 region of the hippocampus for CoSyn-treated TBI animals compared to saline-treated. Reduced numbers of MPO+ cells were also found in the perilesional cortex and hippocampus in CoSyn treated TBI mice compared to their saline-treated counterparts. Furthermore, CoSyn treatment reduced IL1β expression in the cortex of TBI mice. Behavioral testing showed a treatment effect of CoSyn for NOR with CoSyn increasing the discrimination ratio in both TBI and Sham groups, indicating increased memory performance. CoSyn also decreased latency to find platform during the early training period of the MWM when comparing CoSyn to saline-treated TBI mice suggesting moderate improvements in spatial memory following CoSyn treatment.Conclusion: Reduced microglia/macrophage accumulation and neutrophil infiltration in conjunction with moderate improvements in spatial learning in our CoSyn treated TBI mice suggests a beneficial anti-inflammatory effect of CoSyn following TBI.

Highlights

  • Traumatic brain injury (TBI) is a major health concern in the United States resulting in a substantial number of hospitalizations and deaths (Flanagan, 2015)

  • We investigated the effects of a long-acting synthetic adrenocorticotropic hormone (ACTH) analog (CoSyn, ACTH 1–24) on neuroinflammation and immune cell response following experimental TBI in mice and their subsequent functional outcomes

  • We investigated the effect of CoSyn administration in modulating inflammatory and behavioral outcomes following an experimental model of traumatic brain injury in mice

Read more

Summary

Introduction

Traumatic brain injury (TBI) is a major health concern in the United States resulting in a substantial number of hospitalizations and deaths (Flanagan, 2015). Neuroinflammation following TBI is associated with increased intracranial pressure, increased mortality, poor functional outcomes (da Silva Meirelles et al, 2017), reduced processing speed (Ramlackhansingh et al, 2011), and increased risk of epilepsy and neurodegenerative disorders (Appleton and Demellweek, 2002; Faden and Loane, 2015; Cherry et al, 2016). Together, these findings suggest that pharmaceutical agents that modulate inflammation are attractive targets to address acute and chronic symptoms of brain injury

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call